These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 18246981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.
    Morgenthaler TI, Kapur VK, Brown T, Swick TJ, Alessi C, Aurora RN, Boehlecke B, Chesson AL, Friedman L, Maganti R, Owens J, Pancer J, Zak R, Standards of Practice Committee of the American Academy of Sleep Medicine.
    Sleep; 2007 Dec; 30(12):1705-11. PubMed ID: 18246980
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy.
    Mignot E.
    Sleep Med Rev; 2004 Oct; 8(5):333-8. PubMed ID: 15336234
    [No Abstract] [Full Text] [Related]

  • 6. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
    Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E.
    Sleep; 2010 Nov; 33(11):1457-64. PubMed ID: 21102987
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic advances in narcolepsy.
    Thorpy M.
    Sleep Med; 2007 Jun; 8(4):427-40. PubMed ID: 17475553
    [Abstract] [Full Text] [Related]

  • 11. Modafinil: a second look. Confirmed efficacy in narcolepsy.
    Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
    [Abstract] [Full Text] [Related]

  • 12. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 13. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS, Guilleminault C.
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC.
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
    Junnarkar G, Allphin C, Profant J, Steininger TL, Chen C, Zomorodi K, Skowronski R, Black J.
    Expert Opin Drug Discov; 2022 Feb; 17(2):109-119. PubMed ID: 34818123
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.